EPHX2 and chronic kidney disease: Although these changes are unlikely related to altered sEH activity, but rather to the dialysis treatment itself, reduced in vivo sEH activity in CKD/ESRD (Zhang, 2015) may have contributed to the increased accumulation of all four epoxy metabolite classes in our CKD patients, compared to the healthy control subjects.